trending Market Intelligence /marketintelligence/en/news-insights/trending/-ea4tIe1UdVA3qD3-pC_UQ2 content esgSubNav
In This List

Lattice Biologics COO, director resign

Video

S&P Capital IQ Pro | Powering Your Edge

Video

S&P Capital IQ Pro | Unrivaled Sector Coverage

Blog

Enterprises are missing out on 24B by not optimizing cloud spending not going multicloud

Blog

Investment Research Analysts Providing Greater Coverage on Inflation


Lattice Biologics COO, director resign

Darrell Holmes resigned as the COO of Lattice Biologics Inc. to pursue other commercial opportunities, effective Dec. 1.

In addition, Mario Stifano resigned as director due to conflicting time priorities, effective Dec. 12.

Both Holmes and Stifano are eligible to act as an adviser or consultant to Lattice Biologics, and the company may elect to retain their services in the future.